(a) An employee or agent of an authorized entity may not provide or administer an epinephrine auto-injector under this subchapter unless he or she completes an anaphylaxis training program. The training program shall be conducted by:
(1) A nationally recognized organization experienced in training laypersons in emergency health treatment; or
(2) An entity or individual approved by the Department.
(b) The training program may be conducted online or in person and shall include instruction on:
(1) The recognition of signs and symptoms of severe allergic reactions, including anaphylaxis;
(2) Standards and procedures for the storage and administration of an epinephrine auto-injector; and
(3) Post-administration emergency medical follow-up procedures.
(c) An organization, individual, or entity that conducts the training program shall issue a certificate, on a form developed by the Department, to each person who successfully completes the training program.
(Feb. 22, 2019, D.C. Law 22-207, § 5, 65 DCR 12365.)
Applicability of D.C. Law 22-207: § 7155 of D.C. Law 23-16 repealed § 10 of D.C. Law 22-207. Therefore the creation of this section by D.C. Law 22-207 has been implemented.
Applicability of D.C. Law 22-207: § 10 of D.C. Law 22-207 provided that the creation of this section by § 5 of D.C. Law 22-207 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.